Detection of Acquired Janus Kinase 2 V617F Mutation in Myeloproliferative Disorders by Fluorescence Melting Curve Analysis

Author： Reading N. Scott   Lim Megan S.   Elenitoba-Johnson Kojo S.J.  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.10, Iss.5, 2006-01, pp. : 311-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 3-4, 2009-01 ,pp. : 148-159

Karger

Access to resources Recommend Favorite

Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2V617F Mutation Status

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-04 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

Melting Point Assay for the JAK2 V617F Mutation, Comparison with Amplification Refractory Mutation System (ARMS) in Diagnostic Samples, and Implications for Daily Routine

By Ochsenreither Sebastian   Reinwald Mark   Thiel Eckhard   Burmeister Thomas  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 3, 2010-06 ,pp. : 185-190

Adis International

Access to resources Recommend Favorite

Is the JAK2 V617F Mutation a Hallmark for Different Forms of Thrombosis?

By  

Acta Haematologica, Vol. 124, Iss. 1, 2010-07 ,pp. : 49-56

Karger

Access to resources Recommend Favorite

Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd‐Chiari Syndrome without myeloproliferative neoplasm

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 443-445

John Wiley & Sons Inc

Access to resources Recommend Favorite